日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Carbon dot-modified silver nanoparticle electrochemical sensors for the ultrasensitive detection of total malachite green and leucomalachite green residues in fish

碳点修饰的银纳米粒子电化学传感器用于超灵敏检测鱼类中总孔雀石绿和无色孔雀石绿残留量

期刊:RSC Advances
影响因子:4.6
doi:10.1039/d6ra01261b
Boussou Narcisse, Pomi Bi; Martin, Aka Alla; Fodjo, Essy Kouadio; Yang, Guangxin; Kong, Cong; Gu, Zhen; Kra Sylvestre, Koffi Koffi; Irié Williams, Irié Bi
发表日期：2026
文献求助 收藏

Evaluating treatment effectiveness: Complementing RCTs with real-world data

评估治疗效果：利用真实世界数据补充随机对照试验

期刊:American Journal of Health-System Pharmacy
影响因子:
doi:10.1093/ajhp/zxag035
Rivera, Christina G; Mozaffari, Essy; Read, Stephanie H; Kalil, Andre C
发表日期：2026
文献求助 收藏

Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19

对于因新冠肺炎住院的患者，瑞德西韦联合地塞米松治疗较单独使用地塞米松治疗具有更低的死亡风险。

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciae477
Mozaffari, Essy; Chandak, Aastha; Gottlieb, Robert L; Chima-Melton, Chidinma; Berry, Mark; Oppelt, Thomas; Okulicz, Jason F; Amin, Alpesh N; Welte, Tobias; Sax, Paul E; Kalil, Andre C
肺炎
新冠
微生物学
发表日期：2025
文献求助 收藏

A Systematic Review and Meta-analysis of the Effectiveness of Remdesivir to Treat SARS-CoV-2 in Hospitalized Patients: Have the Guidelines Evolved With the Evidence?

瑞德西韦治疗 SARS-CoV-2 住院患者疗效的系统评价和荟萃分析：指南是否随着证据的更新而发展？

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciaf111
Bartoletti, Michele; Mozaffari, Essy; Amin, Alpesh N; Doi, Yohei; Loubet, Paul; Rivera, Christina G; Roshon, Michael; Rawal, Aaditya; Kaiser, Emily; Vutcovici Nicolae, Maria; Fu, Shuai; Oppelt, Thomas F; Chiang, Mel; Sax, Paul E; Kalil, Andre C
SARS-CoV-2
发表日期：2025
文献求助 收藏

Fast detection of melamine using silver nanoparticles capped with l-cysteine functionalized carbon dots

利用L-半胱氨酸功能化碳点修饰的银纳米粒子快速检测三聚氰胺

期刊:RSC Advances
影响因子:4.6
doi:10.1039/d5ra03280f
Kra Sylvestre, Koffi Koffi; Li, Dan; Kouadio Fodjo, Essy; Martin, Aka Alla; Boussou Narcisse, Pomi Bi; Irié Williams, Irié Bi
发表日期：2025
文献求助 收藏

Risk of Long COVID in hospitalized individuals treated with remdesivir for acute COVID-19

接受瑞德西韦治疗的急性新冠肺炎住院患者发生长期新冠的风险

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-06052-3
Berry, Mark; Kong, Amanda M; Paredes, Roger; Paone, Julie; Shah, Rohan; Taylor, Rebecca; Mozaffari, Essy; Gupta, Rikisha; Gottlieb, Robert L; Mateu, Lourdes; Abdelghany, Mazin; Goldman, Jason D; Chokkalingam, Anand P
肺炎
新冠
微生物学
发表日期：2025
文献求助 收藏

Clinical Outcomes of COPD Patients Hospitalized for SARS-Cov-2 Infection During the Omicron Era: Comparative Effectiveness of Initiating Remdesivir in Addition to Corticosteroids Versus Corticosteroids Alone

在奥密克戎时代，因SARS-CoV-2感染住院的COPD患者的临床结局：联合使用瑞德西韦和糖皮质激素与单独使用糖皮质激素的疗效比较

期刊:Viruses-Basel
影响因子:3.5
doi:10.3390/v17111438
Ahuja, Neera; Jiang, Heng; Milano, Marc; Casciano, Roman; Kadambi, Ananth; Oppelt, Thomas; Rezai, Fariborz; Kolditz, Martin; Müller, Veronika; Mozaffari, Essy
SARS-CoV-2
慢性阻塞性肺疾病
炎症/感染
COPD
免疫/内分泌
发表日期：2025
文献求助 收藏

Racial and Ethnic Disparities in COVID-19 Treatments in the United States

美国新冠肺炎治疗中存在的种族和族裔差异

期刊:Journal of Racial and Ethnic Health Disparities
影响因子:2.4
doi:10.1007/s40615-024-01942-0
Mozaffari, Essy; Chandak, Aastha; Amin, Alpesh N; Gottlieb, Robert L; Kalil, Andre C; Sarda, Vishnudas; Berry, Mark; Brown, Gina; Okulicz, Jason F; Chima-Melton, Chidinma
肺炎
新冠
微生物学
发表日期：2025
文献求助 收藏

Remdesivir-Associated Survival Outcomes Among Immunocompromised Patients Hospitalized for COVID-19: Real-world Evidence From the Omicron-Dominant Era

瑞德西韦治疗对新冠肺炎住院免疫功能低下患者的生存结局：来自奥密克戎主导时代的真实世界证据

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciae510
Mozaffari, Essy; Chandak, Aastha; Gottlieb, Robert L; Chima-Melton, Chidinma; Berry, Mark; Amin, Alpesh N; Sax, Paul E; Kalil, Andre C
肺炎
新冠
免疫/内分泌
微生物学
发表日期：2024
文献求助 收藏

Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores

瑞德西韦降低新冠肺炎住院脆弱患者30天内再入院风险的有效性：一项采用倾向评分的美国回顾性队列研究

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciae511
Mozaffari, Essy; Chandak, Aastha; Gottlieb, Robert L; Kalil, Andre C; Jiang, Heng; Oppelt, Thomas; Berry, Mark; Chima-Melton, Chidinma; Amin, Alpesh N
肺炎
新冠
微生物学
发表日期：2024
文献求助 收藏